Invesco Nasdaq is selling at 21.30 as of the 3rd of May 2025; that is 1.38 percent increase since the beginning of the trading day. The etf's last reported lowest price was 21.17. Invesco Nasdaq has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 2nd of February 2025 and ending today, the 3rd of May 2025. Click here to learn more.
The fund generally will invest at least 90 percent of its total assets in the securities that comprise the index. Invesco Nasdaq is traded on NASDAQ Exchange in the United States. More on Invesco Nasdaq Biotechnology
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser
Transfer Agent
The Bank of New York Mellon Corporation
Fiscal Year End
31-Aug
Exchange
NASDAQ
Number of Constituents
269
Market Maker
Latour Trading
Total Expense
0.19
Management Fee
0.19
Country Name
USA
Returns Y T D
(0.84)
Name
Invesco Nasdaq Biotechnology ETF
Currency Code
USD
Open Figi
BBG011B9TYG1
In Threey Volatility
15.55
1y Volatility
15.2
200 Day M A
22.7777
50 Day M A
21.3938
Code
IBBQ
Updated At
2nd of May 2025
Currency Name
US Dollar
In Threey Sharp Ratio
0.09
Invesco Nasdaq Biotechnology [IBBQ] is traded in USA and was established 2021-06-09. The fund is listed under Health category and is part of Invesco family. The entity is thematically classified as Sector ETFs. Invesco Nasdaq Biote currently have 19.84 M in assets under management (AUM). , while the total return for the last 3 years was 4.6%.
Check Invesco Nasdaq Probability Of Bankruptcy
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Invesco Nasdaq. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
When determining whether Invesco Nasdaq Biote is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Invesco Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Invesco Nasdaq Biotechnology Etf. Highlighted below are key reports to facilitate an investment decision about Invesco Nasdaq Biotechnology Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invesco Nasdaq Biotechnology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
The market value of Invesco Nasdaq Biote is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Nasdaq's value that differs from its market value or its book value, called intrinsic value, which is Invesco Nasdaq's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Nasdaq's market value can be influenced by many factors that don't directly affect Invesco Nasdaq's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Nasdaq's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Nasdaq is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Nasdaq's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.